Search For "2 dg"
Rajnath Singh lauds DRDO for developing anti-COVID drug 2-DG
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): Defence Minister Rajnath Singh on Monday lauded the Defence Research and Development Organisation (DRDO) for developing 2-deoxy-D-glucose (2-DG) drug for the treatment of COVID-19.
Read More
DRDO's anti-COVID drug 2-DG will reduce recovery time, oxygen dependency,
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): Union Health Minister Dr Harsh Vardhan on Monday said that the recovery time from COVID-19 infection and oxygen dependency will be reduced by anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO). Read More
Rajnath Singh, Harsh Vardhan release first batch of DRDO's anti-COVID drug
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan on Monday released the first batch of Anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO).
Read More
Rajnath Singh to release first batch of DRDO's 2DG medicine for treating C
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh on Monday.
Read More
DRDO's anti-COVID drug is safe, will help patients recover faster: Dr Sudh
Updated : 5 years ago IST
New Delhi [India], May 9 (ANI): Dr Sudhir Chandna, Institute of Nuclear Medicine and Allied Sciences (INMAS) scientist, on Sunday said the recently approved anti-COVID drug 2-deoxy-D-glucose (2-DG) is completely safe and will help patients recover faster.
Read More
DRDO's anti-COVID 2-DG drug effective against different variants: DRDO sci
Updated : 5 years ago IST
New Delhi [India], May 8 (ANI): The Defence Research and Development Organisation (DRDO)'s new anti-COVID drug, just approved by the Drugs Controller General of India (DCGI) is effective against different variants of the coronavirus and helps in bringing patients out of oxygen support, sa
Read More
DCGI nods anti-COVID drug developed by DRDO for emergency use
Updated : 5 years ago IST
New Delhi [India], May 8 (ANI): The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-COVID drug - 2-deoxy-D-glucose (2-DG) - as an adjunct therapy in moderate to severe COVID-19 cases.
Read More